Department of Medicine Hematology/Oncology |
Hematology/Oncology |
Anemia Anticoagulation Chronic myeloid leukemia Coagulation disorders Essential thrombocytosis Gaucher's disease Hematology Hemochromatosis Monoclonal gammopathy of unknown significance Myelofibrosis Myeloproliferative diseases Platelet Disorders Polycythemia vera Thrombocytopenia Thrombosis and hemostasis |
Boston: Massachusetts General Hospital |
Dphil,Oxford University MD,Harvard Medical School |
Hematology, American Board of Internal Medicine Internal Medicine, American Board of Internal Medicine Medical Oncology, American Board of Internal Medicine |
Male |
Adult |
Yes |
View list » Aetna Health Inc. AllWays Health (NHP) - ACD AllWays Health (NHP) - PBO Beech Street Blue Cross Blue Shield - Blue Care 65 Blue Cross Blue Shield - Indemnity Blue Cross Blue Shield - Managed Care Blue Cross Blue Shield - Partners Plus BMC HealthNet Mass Health MCO/ACO Cigna (PAL #'s) Commonwealth Care Alliance Fallon Community HealthCare Great-West Healthcare (formally One Health Plan) Harvard Pilgrim Health Plan - ACD Harvard Pilgrim Health Plan - PBO Health Care Value Management (HCVM) Humana/Choice Care PPO MassHealth Medicare Medicare - ACD OSW - Maine OSW - New Hampshire OSW - Rhode Island OSW - Vermont Private Health Care Systems (PHCS) Railroad Medicare Railroad Medicare - ACD Senior Whole Health TriCare Tufts Health Plan Unicare United Healthcare (non-HMO) - ACD United Healthcare (non-HMO) - PBO Well Sense Pediatrics « Hide list |
Dr. David Kuter is Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He received his undergraduate degree from Harvard College and his D. Phil. in Biochemistry while a Rhodes Scholar at Oxford University, before obtaining his medical degree from Harvard Medical School. Dr. Kuter divides his time between medical education of fellows and medical students, clinical care of patients with a wide range of hematological disorders, and clinical research of thrombopoietic agents. His basic science group was one of the labs that discovered thrombopoietin and his clinical research group carried out seminal studies using thrombopoietic agents in transfusion medicine and immune thrombocytopenia (ITP). 
Dr Kuter is recipient of a number of awards, including the Irving London Teaching Award at Harvard Medical School, the Alfred Kranes Teaching Award at the Massachusetts General Hospital, the Douglas Family Foundation Prize for Research (2008 and 2010) at Massachusetts General Hospital, the Jane Green Memorial Prize for Teaching at the Massachusetts General Hospital, and the 2013 Earnest Beutler Award from the American Society of Hematology. 
He has given over 500 invited lectures in over 50 countries and served as Visiting Professor in Beijing, Sydney, Tokyo, London, Durham, and New Haven. 
Dr Kuter has authored or co-authored over 300 articles published in international peer-reviewed journals such as The Lancet, The New England Journal of Medicine and Blood.